Eagle Asset Management Inc. cut its holdings in Steris Plc (NYSE:STE) by 1.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 75,586 shares of the medical equipment provider’s stock after selling 1,129 shares during the quarter. Eagle Asset Management Inc. owned approximately 0.09% of Steris Plc worth $6,160,000 as of its most recent SEC filing.
Other large investors have also added to or reduced their stakes in the company. Bragg Financial Advisors Inc purchased a new stake in shares of Steris Plc in the 1st quarter worth about $1,159,000. Morgan Stanley grew its position in shares of Steris Plc by 28.3% in the 1st quarter. Morgan Stanley now owns 266,537 shares of the medical equipment provider’s stock worth $18,514,000 after buying an additional 58,776 shares during the period. Legal & General Group Plc grew its position in shares of Steris Plc by 31.0% in the 1st quarter. Legal & General Group Plc now owns 56,190 shares of the medical equipment provider’s stock worth $3,902,000 after buying an additional 13,294 shares during the period. Russell Investments Group Ltd. grew its position in shares of Steris Plc by 57.5% in the 1st quarter. Russell Investments Group Ltd. now owns 132,035 shares of the medical equipment provider’s stock worth $9,171,000 after buying an additional 48,188 shares during the period. Finally, Washington Capital Management Inc. grew its position in shares of Steris Plc by 35.6% in the 1st quarter. Washington Capital Management Inc. now owns 8,000 shares of the medical equipment provider’s stock worth $556,000 after buying an additional 2,100 shares during the period. 94.67% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Steris Plc (NYSE STE) opened at 86.805 on Friday. Steris Plc has a one year low of $63.80 and a one year high of $88.11. The stock’s 50 day moving average is $85.25 and its 200-day moving average is $77.84. The stock has a market cap of $7.40 billion, a P/E ratio of 62.092 and a beta of 1.29.
Steris Plc (NYSE:STE) last announced its earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 EPS for the quarter, topping the Zacks’ consensus estimate of $0.80 by $0.05. The business had revenue of $608.00 million during the quarter, compared to the consensus estimate of $597.66 million. Steris Plc had a net margin of 4.63% and a return on equity of 11.39%. The firm’s revenue was down 4.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.79 earnings per share. On average, equities analysts forecast that Steris Plc will post $4.06 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Thursday, September 28th. Shareholders of record on Tuesday, August 29th will be issued a $0.31 dividend. The ex-dividend date is Friday, August 25th. This is an increase from Steris Plc’s previous quarterly dividend of $0.28. This represents a $1.24 dividend on an annualized basis and a yield of 1.43%. Steris Plc’s payout ratio is currently 88.57%.
Several brokerages recently commented on STE. Raymond James Financial, Inc. increased their price objective on shares of Steris Plc from $90.00 to $95.00 and gave the company an “outperform” rating in a research report on Wednesday, August 9th. Zacks Investment Research downgraded shares of Steris Plc from a “buy” rating to a “hold” rating in a research report on Tuesday, August 22nd. BidaskClub downgraded shares of Steris Plc from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Finally, Wellington Shields downgraded shares of Steris Plc from a “gradually accumulate” rating to a “hold” rating in a research report on Monday, June 5th. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Steris Plc has a consensus rating of “Buy” and an average target price of $86.75.
In other news, Director Richard Martin Steeves sold 156,072 shares of the business’s stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $87.13, for a total transaction of $13,598,553.36. Following the sale, the director now owns 9,362 shares in the company, valued at $815,711.06. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Michael B. Wood sold 4,000 shares of the business’s stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $81.50, for a total value of $326,000.00. Following the sale, the director now owns 26,131 shares in the company, valued at approximately $2,129,676.50. The disclosure for this sale can be found here. Insiders sold 176,086 shares of company stock valued at $15,297,621 over the last quarter. 2.55% of the stock is currently owned by corporate insiders.
Steris Plc Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with our FREE daily email newsletter.